Healthcare >> CEO Interviews >> October 26, 1998

Ronald W. Dollens – Guidant Corporation (gdt)

RONALD W. DOLLENS is President and Chief Executive Officer of Guidant Corporation. Prior to the formation of Guidant, Mr. Dollens served as President of Eli Lilly and Company's Medical Devices and Diagnostics Division (MDD). In 1985, Mr. Dollens was named Senior Vice President, Sales, Marketing, and Product Development for Advanced Cardiovascular Systems, Inc. (ACS), an MDD company headquartered in Santa Clara, California. In 1988, he became President and Chief Executive Officer of ACS. He assumed his current post as President and Chief Executive Officer of Guidant when the company was formed in 1994. Mr. Dollens received a Bachelor of Science degree in pharmacy from Purdue University and a Master of Business Administration degree in Marketing from Indiana University. Mr. Dollens is a member of the Boards of Advanced Medical Technology Association (AdvaMed, formerly HIMA), Alliance for Aging Research, Healthcare Leadership Council, Indiana Health Industry Forum, Kennetic Concepts Inc., and Beckman Coulter Corporation. Active in civic affairs, he also serves on the Boards of Butler University, Eiteljorg Museum, St. Vincent Hospital Foundation and the Indiana State Symphony Society. Additionally, Mr. Dollens has been appointed by U.S. Health and Human Services Secretary Tommy G. Thompson to serve on the newly created Advisory Committee on Regulatory Reform. Profile
TWST: Could you give us just enough of a brief summary, a bit of an

historical background on Guidant that places us in a context as to what

you see as your company today and what you see as your